Total Payments
$11,815
2024 Payments
$1,263
Companies
43
Transactions
532
Medicare Patients
5,240
Medicare Billing
$185,854
Payment Breakdown by Category
Food & Beverage$10,274 (87.0%)
Travel$1,355 (11.5%)
Education$186.69 (1.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,274 | 524 | 87.0% |
| Travel and Lodging | $1,355 | 4 | 11.5% |
| Education | $186.69 | 4 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,031 | 35 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,732 | 103 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,314 | 64 | $0 (2024) |
| Amgen Inc. | $1,018 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $896.28 | 41 | $0 (2023) |
| PFIZER INC. | $794.18 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $727.78 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $279.63 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $260.58 | 19 | $0 (2024) |
| Gilead Sciences, Inc. | $218.26 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,263 | 64 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($228.21) |
| 2023 | $1,217 | 58 | Novartis Pharmaceuticals Corporation ($419.10) |
| 2022 | $710.90 | 32 | Novartis Pharmaceuticals Corporation ($155.43) |
| 2021 | $1,091 | 48 | AstraZeneca Pharmaceuticals LP ($160.67) |
| 2020 | $840.46 | 46 | Amgen Inc. ($200.73) |
| 2019 | $1,648 | 93 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($294.95) |
| 2018 | $1,443 | 73 | PFIZER INC. ($212.89) |
| 2017 | $3,601 | 118 | Medtronic Vascular, Inc. ($1,813) |
All Payment Transactions
532 individual payment records from CMS Open Payments — Page 2 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.92 | General |
| Category: Cardiovascular | ||||||
| 06/27/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Genetic Disease | ||||||
| 06/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.67 | General |
| Category: Cardiovascular | ||||||
| 06/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: DIABETES | ||||||
| 06/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.75 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.59 | General |
| Category: Cardiovascular | ||||||
| 06/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.90 | General |
| 06/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.25 | General |
| Category: Cardiovascular | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Cardiovascular | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/02/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/26/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $57.89 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,476 | 2,051 | $169,919 | $47,237 |
| 2022 | 7 | 1,337 | 1,832 | $152,344 | $46,772 |
| 2021 | 9 | 1,342 | 1,758 | $174,376 | $54,427 |
| 2020 | 8 | 1,085 | 1,515 | $135,287 | $37,418 |
Total Patients
5,240
Total Services
7,156
Medicare Billing
$185,854
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 145 | 221 | $45,510 | $11,402 | 25.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,022 | 1,426 | $28,520 | $10,065 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 105 | $30,200 | $7,915 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 26 | 26 | $10,380 | $3,043 | 29.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $10,650 | $2,742 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 39 | 39 | $9,360 | $2,669 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 33 | $7,180 | $2,240 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 46 | $9,300 | $2,088 | 22.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 17 | $7,090 | $1,860 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $5,669 | $1,433 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 15 | $4,200 | $1,180 | 28.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 64 | 93 | $1,860 | $599.23 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 113 | 189 | $36,310 | $10,354 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 86 | 120 | $34,050 | $10,264 | 30.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 933 | 1,255 | $25,100 | $9,477 | 37.8% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 18 | 19 | $13,994 | $3,913 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 40 | 40 | $10,000 | $3,115 | 31.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 27 | $10,530 | $3,030 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 34 | $6,800 | $2,225 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 41 | $7,870 | $2,049 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 21 | $5,970 | $1,766 | 29.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 57 | 86 | $1,720 | $578.55 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 107 | 154 | $39,270 | $13,075 | 33.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 880 | 1,153 | $33,437 | $8,672 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 97 | 125 | $21,875 | $7,731 | 35.3% |
About Dr. Michael Friedman, MD
Dr. Michael Friedman, MD is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285692517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Friedman, MD has received a total of $11,815 in payments from pharmaceutical and medical device companies, with $1,263 received in 2024. These payments were reported across 532 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,274).
As a Medicare-enrolled provider, Friedman has provided services to 5,240 Medicare beneficiaries, totaling 7,156 services with total Medicare billing of $185,854. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Brooklyn, NY
- Active Since 05/03/2006
- Last Updated 10/29/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285692517
Products in Payments
- CoreValve Evolut (Device) $1,679
- ENTRESTO (Drug) $1,597
- LifeVest (Device) $1,314
- ELIQUIS (Drug) $798.01
- BRILINTA (Drug) $777.34
- XARELTO (Drug) $724.66
- Corlanor (Drug) $553.95
- Repatha (Biological) $455.58
- Resolute (Device) $315.74
- MULTAQ (Drug) $266.35
- VERQUVO (Drug) $179.67
- HeartMate (Device) $142.09
- LOKELMA (Drug) $139.18
- Veltassa (Drug) $138.75
- LEQVIO (Drug) $134.73
- CAMZYOS (Drug) $132.40
- JARDIANCE (Drug) $119.58
- Impella (Device) $117.16
- PRALUENT ALIROCUMAB INJECTION (Biological) $99.01
- Adempas (Drug) $95.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799